Our previous study showed that the decreased ISR via PERK heterozygous deficiency enhances pre-malignant GCP apoptosis, resulting in the reduction of medulloblastoma incidence in Ptch1+/− mice [27]. This evidence concerns the gene PTCH1 and medulloblastoma.